Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings
Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings
Stock futures were pointing to a higher open even before Goldman Sachs (NYSE:GS) reported better than expected earnings. Goldman rose 2.25% before the open helping to lead another group of financial stocks that have kicked off a strong earnings season. PNC Financial (NYSE:PNC) and Truist Financial Corp (NYSE:TFC) were among the group of financial stocks that also beat on earnings and revenue estimates. Financials continue to benefit from the rise in yields, but supply chain and inflation problems are likely to be factors as other market sectors begin to report next week.
股指期货甚至在此之前就指向更高的开盘价高盛(纽约证券交易所代码:GS)公布的收益好于预期。高盛在开盘前上涨了2.25%,帮助领涨了另一批金融股,这些股票拉开了强劲财报季的序幕。PNC金融(纽约证券交易所代码:PNC)和TRUIST FINANCIAL CORPORATION(纽约证券交易所股票代码:TFC)是盈利和营收预期也超过预期的金融股之一。金融股继续受益于收益率上升,但随着其他市场板块下周开始公布财报,供应链和通胀问题可能成为影响因素。
The Real Estate Select Sector Index ($IXRE) has been able to keep up with the S&P 500 (SPX) despite rising interest rates. On Friday morning, Prologis (NYSE:PLD) reported better-than-expected earnings and revenue leading to a premarket rally of 1.86%. The company saw a record increase in rents and a rise in occupancy.
这个房地产精选行业指数($IXRE)能够跟上标准普尔500指数(SPX)尽管利率上升。周五早上,开场白(纽约证券交易所代码:PLD)公布的收益和收入好于预期,导致盘前上涨1.86%。该公司的租金创历史新高,入住率也有所上升。
Trucking company JB Hunt (NASDAQ:JBHT) was 2.8% higher in premarket trading after announcing that it beat estimates on earnings and revenue. The company has benefited from high demand as trucking is a central piece of the supply chain. JB Hunt reported growth in all business segments which helped to offset rising wages and the cost of new trucks. A strong transportation sector is often a good sign for the economy because it’s an indicator of demand.
卡车运输公司JB Hunt纳斯达克股票代码:JBHT)在盘前交易中上涨2.8%,此前该公司宣布收益和收入超出预期。由于卡车运输是供应链的核心部分,该公司受益于高需求。JB Hunt报告称,所有业务部门都出现了增长,这有助于抵消工资上涨和新卡车成本上涨的影响。强劲的运输业通常是经济的好兆头,因为它是需求的指标。
A couple of stocks are down in premarket trading. Corsair Gaming (NASDAQ:CRSR) fell 5.5% before the open after reducing its third-quarter revenue guidance. The company cited supply chain issues for the lower outlook. Virgin Galactic (NYSE:SPCE) fell 18% because the company had to delay the launch of its commercial space tourism business until next year.
有几只股票在盘前交易中下跌。海盗船游戏纳斯达克股票代码:CRSR)开盘前下跌5.5%,此前该公司下调了第三季度营收指引。该公司将较低的前景归咎于供应链问题。维珍银河(纽约证券交易所代码:SPCE)股价下跌18%,因为该公司不得不将其商业太空旅游业务的推出推迟到明年。
In economic news, the Census Bureau released the monthly U.S. Retail Sales numbers for September on Friday morning which came in much higher than expected. However, the numbers are being driven in part by higher inflation. Stock futures were unchanged immediately after the news.
在经济新闻方面,美国人口普查局周五上午公布了美国9月份的月度零售销售数据,远远高于预期。然而,这些数字在一定程度上是由更高的通胀推动的。消息传出后,股指期货立即保持不变。
Sector Wellness
行业健康状况
UnitedHealth Group (NYSE:UNH) climbed more than 4% on Thursday after announcing better-than-expected earnings, but the stock struggled to break a resistance level near $425. UNH has been testing this level since May but has been turned back by sellers. The positive announcement could help the stock eventually break resistance, but weakness in the sector could be a drag on the company.
联合健康集团纽约证券交易所(NYSE:UNH)周四公布好于预期的盈利后,股价攀升逾4%,但该股难以突破425美元附近的阻力位。自5月以来,UNH一直在测试这一水平,但遭到卖家的拒绝。这一利好的声明可能有助于该股最终突破阻力,但该板块的疲软可能拖累该公司。
One problem with the Health Care sector is that COVID-19 and staff shortages are making elective procedures and regular health care more difficult. Last month, The New York Times reported that some hospitals were postponing surgeries for hernias, hip replacements, cancer, and heart surgeries because of the lack of beds. Recently, the Washington Post reported that coronavirus cases are falling, which could allow for more elective procedures.
医疗保健部门的一个问题是,新冠肺炎和人员短缺正在使选择性程序和常规医疗变得更加困难。上个月,《纽约时报》报道称,由于床位不足,一些医院推迟了疝气、髋关节置换、癌症和心脏手术。最近,华盛顿邮报报道称,冠状病毒病例正在下降,这可能会允许进行更多的选择性程序。
Despite the falling cases, many news agencies including Newsweek and BBC are reporting hospital staffing shortages, which means that even if rooms and beds are open, there may not be enough staff to help with treatments. Despite these shortages, medical staffing companies’ stock prices have been falling. AMN Healthcare (NYSE:AMN) has fallen more than 17% in the last two days, while Cross Country Healthcare (NASDAQ:CCRN) and Heidrick & Struggles (NASDAQ:HSII) are both down 15% and 6% respectively from their 52-week highs set just four days ago. Yet, there’s no news on what could be driving the sell-off.
尽管案件不断下降,但包括新闻周刊和英国广播公司据报道,医院人员短缺,这意味着即使房间和床位开放,也可能没有足够的工作人员来帮助治疗。尽管出现了这些短缺,但医疗人力公司的股价一直在下跌。AMN Healthcare(纽约证券交易所代码:AMN)在过去两天下跌超过17%,而越野医疗(纳斯达克股票代码:CCRN)和Heidrick&Struggles纳斯达克股票代码:HSII)均较四天前创下的52周高点分别下跌15%和6%。然而,目前还没有关于可能是什么推动了抛售的消息。
The high degree of uncertainty around health care could make it difficult for investors to diagnosis where the sector may be going.
围绕医疗保健的高度不确定性可能使投资者难以诊断该行业可能走向何方。
CHART OF THE DAY: FLATLINING. UnitedHealth (UNH—pink) rallied on its earnings announcement but failed to sustain a break above resistance. One negative factor is the weakness in the S&P Health Care Select Sector Index ($IXV—candlesticks). Health Care is underperforming the S&P 500 (SPX—blue) in both comparative performance and relative strength (green line).
当日图表:压平了。UnitedHealth(UNH-PINK)在公布财报后上涨,但未能维持突破阻力位。一个负面因素是标准普尔医疗保健精选板块指数(IXV-烛台)的疲软。Health Care在相对表现和相对实力(绿线)方面都落后于标准普尔500指数(SPX-Blue)。
Data Sources: ICE, S&P Dow Jones Indices. Chart source: The thinkorswim® platform. For illustrative purposes only. Past performance does not guarantee future results.
数据来源:ICE,标普道琼斯指数图表来源:Thinkkorswm®平台。仅供说明之用。过去的表现并不能保证未来的结果。
Booster Shots: On the positive side of health care, vaccine maker Moderna (NASDAQ:MRNA) received a unanimous recommendation from the FDA advisory committee for its COVID-19 booster shot. The shot is recommended for patients older than 65 or at high risk. The news was a “shot in the arm” for Moderna, which was hit hard when Merck & Co Inc. (NYSE:MRK) released its testing results for its COVID-19 booster. The stock rallied more than 3% on the news but is still down 30% from its August high. Despite its recent struggles, Moderna is up more than 2000% in the last two years.
助推器注射:从医疗保健的积极一面来看,疫苗制造商现代派(纳斯达克股票代码:mRNA)收到了美国食品和药物管理局顾问委员会对其新冠肺炎强化注射的一致推荐。建议65岁以上或高危患者注射该疫苗。这一消息对摩德纳来说是一剂“强心针”,当时该公司受到了沉重的打击。默沙东。纽约证券交易所代码:MRK)公布了其新冠肺炎助推器的测试结果。消息传出后,该股上涨逾3%,但仍较8月高点下跌30%。尽管最近举步维艰,但摩登那在过去两年里上涨了2000%以上。
An FDA panel is expected to meet and discuss a booster shot for the Johnson & Johnson (NYSE:JNJ) vaccine today.
美国食品和药物管理局的一个小组预计将开会讨论强生(纽约证券交易所股票代码:JNJ)今天开始接种疫苗。
Symbiotic Relationships: Moderna was struggling to stay in business before its COVID-19 vaccine. Now, the stock is part of the S&P 500. The success with its vaccine should give the company the capital it needs to potentially get more of its drugs to market.
共生关系:在推出新冠肺炎疫苗之前,现代汽车正艰难地维持着业务。现在,这只股票是标准普尔500指数的一部分。疫苗的成功应该会给该公司带来所需的资金,使其有可能将更多的药物推向市场。
Biotech stocks have also been weak despite being a favorite among aggressive growth investors. The Nasdaq Biotech Index (NBI) is trading near where it started the year. Unfortunately, new science and early-stage success doesn’t guarantee FDA approval. Additionally, a small portfolio of drugs provides a lot of risk for biotech companies, or they depend heavily on partnerships with other drug companies. For example, Seagen (NASDAQ:SGEN) creates antibody-drug conjugates used in monoclonal antibodies. The company has three drugs Adcetris, Padcev, and Tukysa. However, Adcetris accounts for the majority of sales that come from a partnership with Takeda Pharmaceuticals (NYSE:TAK) and licensing revenue from Merck.
生物科技股也一直疲软,尽管它是激进的成长型投资者的最爱。这个纳斯达克生物技术指数(NBI)目前的交易价格接近今年年初的水平。不幸的是,新的科学和早期的成功并不能保证FDA的批准。此外,少量的药物组合给生物技术公司带来了很大的风险,或者他们严重依赖于与其他制药公司的合作伙伴关系。例如,SeaGen(纳斯达克市场代码:SGEN)制造用于单克隆抗体的抗体-药物结合物。该公司有三种药物Adcetris,Padcev和Tukysa。然而,Adcetris的大部分销售额来自与武田制药(纽约证券交易所股票代码:TAK)和默克公司的许可收入。
In a Heartbeat: Despite the weakness in much of the Health Care sector, there appears to be some life in medical device companies. The Dow Jones U.S. Medical Equipment Index ($DJUSAM) bounced off support around the 2830 level on Thursday. The bounce appears to be driven by companies like Stryker Corporation (NYSE:SYK), Becton Dickson (NYSE:BDX), and Medtronic (NYSE:MDT), all of which experienced similar bounces. While there’s little news around the industry group, it’s exhibiting greater relative strength than other industries in the sector.
在一个心跳声中:尽管医疗保健行业的大部分行业表现疲软,但医疗器械公司似乎有了一些生机。这个道琼斯美国医疗设备指数($DJUSAM)周四从2,830水准附近的支撑位反弹。这种反弹似乎是由像这样的公司推动的史泰克公司(纽约证券交易所代码:SYK),贝顿·迪克森(纽约证券交易所代码:BDX),以及美敦力(纽约证券交易所股票代码:MDT),所有股票都经历了类似的反弹。虽然关于这个行业集团的消息很少,但它比该行业的其他行业表现出了更大的相对实力。
TD Ameritrade® commentary for educational purposes only. Member SIPC.
TD ameritrade®评论仅用于教育目的。成员SIPC。
Image Sourced from Pixabay
图片来源:Pixabay